Sex difference in the association of metabolic syndrome with high sensitivity C-reactive protein in a Taiwanese population

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Lai, Ming May ^a,b   Li, Chia Ing ^a   Kardia, Sharon Lr ^c   Liu, Chiu Shong ^a,b   Lin, Wen Yuan ^a,b   Lee, Yih Dar ^d,e   Chang, Pei Chia ^a   Lin, Cheng Chieh ^a,b,f   Li, Tsai Chung ^a,f  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c UNIVERSITY OF MICHIGAN   (United States)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e BRISTOL MYERS SQUIBB   (United States)

^f ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

AGED; ANTHROPOMETRY; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HEALTH BEHAVIOR; HUMAN; IMMUNOLOGY; INFLAMMATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; RISK; SEX DIFFERENCE; TAIWAN;

AGED; ANTHROPOMETRY; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH BEHAVIOR; HUMANS; INFLAMMATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; REGRESSION ANALYSIS; SEX FACTORS; TAIWAN;

EID: 77954665600     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-429     Document Type: Article

References (46)

1. The metabolic syndrome and chronic kidney disease in U.S. adults. J Chen P Muntner LL Hamm DW Jones V Batuman V Fonseca PK Whelton J He, Ann Intern Med 2004 140 167 174 14757614
2. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
3. Cardiovascular morbidity and mortality associated with the metabolic syndrome. B Isomaa P Almgren T Tuomi B Forsén K Lahti M Nissén MR Taskinen L Groop, Diabetes Care 2001 24 683 689 10.2337/diacare.24.4.683 11315831
4. Genetics of the metabolic syndrome. L Groop, Br J nutr 2000 83 suppl 1 39 S48 10889791
5. Sociodemographic and psychological factors are associated with features of the metabolic syndrome: the Women's Health in the Lund Area (WHILA) study. J Lidfeldt P Nyberg C Nerbrand G Samsioe B Scherstén CD Agardh, Diabetes Obes Metab 2003 5 106 112 10.1046/j.1463-1326.2003.00250.x 12630935
6. C-reactive protein, interleukin 6, and the risk of developing type 2 diabetes mellitus. AD Pradhan JE Manson N Rifai JE Buring PM Ridker, JAMA 2001 286 327 334 10.1001/jama.286.3.327 11466099
7. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. DJ Freeman J Norrie MJ Caslake A Gaw I Ford GD Lowe DS O'Reilly CJ Packard N Sattar, Diabetes 2002 51 1596 1600 West of Scotland Coronary Prevention Study 10.2337/diabetes.51.5.1596 11978661
8. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. PM Ridker M Cushman MJ Stampfer RP Tracy CH Hennekens, N Engl J Med 1997 336 973 979 10.1056/NEJM199704033361401 9077376
9. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. PM Ridker CH Hennekens JE Buring N Rifai, N Engl J Med 2000 342 836 843 10.1056/NEJM200003233421202 10733371 (Pubitemid 30165206)
10. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. PM Ridker N Rifai M Clearfield JR Downs SE Weis JS Miles AM Gotto Jr, N Engl J Med 2001 344 1959 1965 Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators 10.1056/NEJM200106283442601 11430324
11. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. RP Tracy RN Lemaitre BM Psaty DG Ives RW Evans M Cushman EN Meilahn LH Kuller, Arterioscler Thromb Vasc Biol 1997 17 1121 1127 9194763
12. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring trends and determinants in cardiovascular disease) Augsberg Cohort Study, 1984 to 1992. W Koenig M Sund M Fröhlich HG Fischer H Löwel A Döring WL Hutchinson MB Pepys, Circulation 1999 99 237 242 9892589
13. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. PM Ridker MJ Stampfer N Rifai, JAMA 2001 285 2481 2485 10.1001/jama.285.19.2481 11368701
14. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. J Danesh JG Wheeler GM Hirschfield S Eda G Eiriksdottir A Rumley GD Lowe MB Pepys V Gudnason, N Engl J Med 2004 350 1387 1397 10.1056/NEJMoa032804 15070788
15. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. PM Ridker N Rifai L Rose JE Buring NR Cook, N Engl J Med 2002 347 1557 1565 10.1056/NEJMoa021993 12432042
16. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case control study. LH Kuller RP Tracy J Shaten EN Meilahn, Am J Epidemiol 1996 144 537 547 8797513
17. C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study. AR Folsom N Aleksic D Catellier HS Juneja KK Wu, Am Heart J 2002 144 233 238 10.1067/mhj.2002.124054 12177639 (Pubitemid 34879645)
18. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. PM Ridker JE Buring J Shih M Matias CH Hennekens, Circulation 1998 98 731 733 9727541
19. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. MA Mendall P Patel L Ballam D Strachan TC Northfield, BMJ 1996 312 1061 1065 8616412
20. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? JS Yudkin CD Stehouwer JJ Emeis SW Coppack, Arterioscler Thromb Vasc Bio 1999 19 972 978
21. Gender and C-reactive protein: Data from the Multiethnic Study of Atherosclerosis (MESA) cohort. SG Lakoski M Cushman M Criqui T Rundek RS Blumenthal RB D'Agostino Jr DM Herrington, Amer Heart J 2006 152 3 593 598 10.1016/j.ahj.2006.02.015 16923436
22. Diagnosis and management of the metabolic syndrome: an American heart Association/National Heart, Lung, and Blood Institute Scientific Statement. SM Grundy JI Cleeman SR Daniels KA Donato RH Eckel BA Franklin DJ Gordon RM Krauss PJ Savage SC Smith Jr JA Spertus F Costa, Circulation 2005 112 17 2735 2752 American Heart Association; National Heart, Lung, and Blood Institute 10.1161/CIRCULATIONAHA.105.169404 16157765 (Pubitemid 41532612)
23. The Relationship between Visfatin Levels and Anthropometric and Metabolic Parameters: Association with Cholesterol Levels in Women. C Chen TC Li CI Li CS Liu WY Lin MT Wu MM Lai CC Lin, Metabolism 2007 56 1216 1220 10.1016/j.metabol.2007.04.018 17697864
24. Microalbuminuria and the metabolic syndrome and its components in the Chinese population. CC Lin CS Liu TC Li CC Chen CI Li WY Lin, European Journal of Clinical Investigation 2007 37 10 783 790 10.1111/j.1365-2362.2007.01865.x 17888089
25. Metabolic Syndrome and Its Associated Risk Factors in a Taiwanese Metropolitan Adult Population. CC Lin CS Liu MM Lai CI Li CC Chen PC Chang WY Lin YD Lee T Lin TC Li, BMC Public Health 2007 7 1 739 743
26. In addition to insulin resistance and obesity, hyperuricemia is strongly associated with metabolic syndrome using different definitions in Chinese populations: a population-based study (Taichung Community Health Study). WY Lin CS Liu TC Li Lin Tsann Chen Walter CC Chen CI Li CC Lin, Ann Rheum Dis 2008 67 3 432 433 10.1136/ard.2007.073601 18292110
27. Association among cigarette smoking, metabolic syndrome and its individual components: the metabolic syndrome study in Taiwan. CC Chen TC Li PC Chang CS Liu WY Lin MT Wu CI Li MM Lai CC Li, Metabolism 2008 57 544 548 10.1016/j.metabol.2007.11.018 18328358
28. New bioimpedance analysis system: improved phenotyping with whole-body analysis. A Pietrobelli F Rubiano MP St Onge SB Heymsfield, Eur J Clin Nutr 2004 58 1479 1484 10.1038/sj.ejcn.1601993 15138459
29. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner, Diabetologia 1985 28 7 412 419 10.1007/BF00280883 3899825
30. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. NK Foundation, Am J Kidney Dis 2002 39 2 Suppl 1 1 266 11904577
31. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. A Yamashina H Tomiyama K Takeda H Tsuda T Arai K Hirose Y Koji S Hori Y Yamamoto, Hypertens Res 2002 25 359 364 10.1291/hypres.25.359 12135313
32. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. JI Weitz J Byrne GP Clagett ME Farkouh JM Porter DL Sackett DE Strandness Jr LM Taylor, Circulation 1996 94 3026 3049 8941154
33. Prediction of coronary heart disease using risk factor categories. PW Wilson RB D'Agostino D Levy AM Belanger H Silbershatz WB Kannel, Circulation 1998 97 1837 1847 9603539
34. Betel-quid use is associated with the risk of the metabolic syndrome in adults. JY Guh LY Chuang HC Chen, Am J Clin Nutr 2006 83 1313 1320 16762942
35. A population-based study of the association between areca nut chewing and type 2 diabetes mellitus in men (Keelung Community-based Integrated Screening programme No. 2). TH Tung YH Chiu LS Chen HM Wu BJ Boucher TH Chen, Diabetologia 2004 47 1776 1781 Keelung Community-based Integrated Screening programme No. 2 10.1007/s00125-004-1532-2 15517150
36. Association between betelnut chewing and chronic kidney disease in adults. IM Kang CY Chou YH Tseng CC Huang WY Ho CM Shih W Chen, J Occup Environ Med 2007 49 776 779 10.1097/JOM.0b013e318095a48a 17622851
37. Betel nut chewing is associated with increased risk of cardiovascular disease and all-cause mortality in Taiwanese men. WY Lin TY Chiu LT Lee CC Lin CY Huang KC Huang, Am J Clin Nutr 2008 87 1204 1211 18469240
38. The metabolic syndrome: a historical context. Gaetano Crepaldi Stefania Maggi, Diabetes voice 2006 51 8 10
39. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. DE Laaksonen L Niskanen K Nyyssönen K Punnonen TP Tuomainen VP Valkonen R Salonen JT Salonen, Diabetologia 2004 47 1403 1410 10.1007/s00125-004-1472-x 15309290
40. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. PM Ridker JE Buring NR Cook N Rifai, Circulation 2003 107 391 397 10.1161/01.CIR.0000055014.62083.05 12551861
41. Association of C-reactive Protein, Smoking and Metabolic Syndrome Among the Health Check-up Population. KL Chien HC Hsu MF Chen YT Lee, Acta Cardiol Sin 2005 21 98 104
42. Distributions of C-Reactive Protein and its Association With Metabolic Syndrome in Middle-Aged and Older Chinese People. X Ye Z Yu H Li OH Franco Y Liu X Lin, J Am Coll Cardiol 2007 49 1798 1805 10.1016/j.jacc.2007.01.065 17466231
43. Gender differences relating to metabolic syndrome and proinflammation in Finnish subjects with elevated blood pressure. T Ahonen J Saltevo M Laakso H Kautiainen E Kumpusalo M Vanhala, Mediators Inflamm 2009 959281
44. Modulation of C-reactive proteinmediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. V Pasceri JS Cheng JT Willerson ET Yeh, Circulation 2001 103 2531 2534 11382718
45. An outpatient-based clinical program for type 2 diabetes prevention. S Bersoux KL Asbury CB Cook JL Verheijde MH Larson RT Aponte-Furlow SS Flatten SA Hooley CS LaRosa KM Seifert PM Verona JC Castro KA Jameson, Endocrine Practice 2010 16 1 21 29 10.4158/EP09151.OR 19703810
46. Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes. JB Albu LK Heilbronn DE Kelley SR Smith K Azuma ES Berk FX Pi-Sunyer E Ravussin, Diabetes 2010 59 3 627 33 Look AHEAD Adipose Research Group 10.2337/db09-1239 20028945